Nadolol 40 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature, avoid excessive heat. Protect from light.
Key facts
- Active ingredient (INN)
- Nadolol
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 1000 tablets and 29 more
- Manufacturers
- Zydus LifesciencesIndiaAlembic PharmaceuticalsIndiaCiplaIndiaUnichem LaboratoriesIndiaAurobindo PharmaIndiaAmneal Pharmaceuticals NYBluePoint LaboratoriesAmerican Health PackagingBryant Ranch PrepackExelan Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at room temperature, avoid excessive heat. Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C07AA12 Nadolol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 February 2016
- Identifiers
- RxCUI 198006, 198007, 198008DailyMed set ID 15822faf-6924-4a63-a4e1-6058b308708c, 44c5352d-89f8-4bd3-9479-1069304562ca, 9acc0c81-4145-43cc-b31a-7b1e3313259d +14NDC 68001-631, 59651-251, 60687-898 +14Application ANDA210955, ANDA201893, ANDA211763 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 46708-403-30 | Alembic PharmaceuticalsIndia | 8 June 2023 |
| 100 tablet in 1 bottle | 46708-403-31 | Alembic PharmaceuticalsIndia | 8 June 2023 |
| 1000 tablet in 1 bottle | 46708-403-91 | Alembic PharmaceuticalsIndia | 8 June 2023 |
| 30 tablet in 1 bottle | 62332-403-30 | Alembic PharmaceuticalsIndia | 8 June 2023 |
| 100 tablet in 1 bottle | 62332-403-31 | Alembic PharmaceuticalsIndia | 8 June 2023 |
| 1000 tablet in 1 bottle | 62332-403-91 | Alembic PharmaceuticalsIndia | 8 June 2023 |
| 100 tablet in 1 bottle | 68382-733-01 | Zydus LifesciencesIndia | 8 August 2017 |
| 1000 tablet in 1 bottle | 68382-733-10 | Zydus LifesciencesIndia | 8 August 2017 |
| 90 tablet in 1 bottle | 68382-733-16 | Zydus LifesciencesIndia | 8 August 2017 |
| 10 blister pack in 1 carton / 1 tablet in 1 blister pack | 68382-733-77 | Zydus LifesciencesIndia | 8 August 2017 |
| 1000 tablet in 1 bottle | 70771-1090-0 | Zydus LifesciencesIndia | 8 August 2017 |
| 100 tablet in 1 bottle | 70771-1090-1 | Zydus LifesciencesIndia | 8 August 2017 |
| 10 blister pack in 1 carton / 1 tablet in 1 blister pack | 70771-1090-4 | Zydus LifesciencesIndia | 8 August 2017 |
| 90 tablet in 1 bottle | 70771-1090-9 | Zydus LifesciencesIndia | 8 August 2017 |
| 100 tablet in 1 bottle | 59651-251-01 | Aurobindo PharmaIndia | 29 October 2021 |
| 30 tablet in 1 bottle | 69097-868-02 | CiplaIndia | 23 February 2016 |
| 100 tablet in 1 bottle | 69097-868-07 | CiplaIndia | 23 February 2016 |
| 1000 tablet in 1 bottle | 69097-868-15 | CiplaIndia | 23 February 2016 |
| 100 tablet in 1 bottle | 76385-134-01 | Unichem LaboratoriesIndia | 26 July 2019 |
| 1000 tablet in 1 bottle | 76385-134-10 | Unichem LaboratoriesIndia | 26 July 2019 |
| 1000 tablet in 1 bottle | 69238-1124-1 | Amneal Pharmaceuticals NY | 2 June 2017 |
| 30 tablet in 1 bottle | 69238-1124-3 | Amneal Pharmaceuticals NY | 2 June 2017 |
| 90 tablet in 1 bottle | 69238-1124-9 | Amneal Pharmaceuticals NY | 2 June 2017 |
| 100 tablet in 1 bottle | 76282-348-01 | Exelan Pharmaceuticals | 27 July 2020 |
| 100 tablet in 1 bottle, plastic | 72664-212-01 | VGYAAN Pharmaceuticals | 30 June 2020 |
| 100 tablet in 1 bottle | 68001-318-00 | BluePoint Laboratories | 31 January 2017 |
| 100 tablet in 1 bottle | 68001-631-00 | BluePoint Laboratories | 24 February 2025 |
| 100 tablet in 1 bottle | 68001-691-00 | BluePoint Laboratories | 30 March 2026 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 60687-898-21 | American Health Packaging | 8 October 2025 |
| 100 tablet in 1 bottle | 72162-2233-1 | Bryant Ranch Prepack | 26 January 2024 |
| 100 tablet in 1 bottle | 51407-978-01 | Golden State Medical Supply | 1 April 2025 |
| 50 pouch in 1 box / 1 tablet in 1 pouch | 70518-4662-0 | Remedyrepack | 18 May 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 December 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nadolol
Clinical summary
Nadolol is a beta-adrenergic blocker indicated for the long-term management of patients with angina pectoris. It is available as tablets for oral use. MedsAcross supplies Nadolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NadololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nadolol prescribing information (BluePoint Laboratories) · U.S. National Library of Medicine, DailyMed
Need Nadolol 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.